Astera Labs (NASDAQ:ALAB) Shares Up 12.4% - Still a Buy?

Key Points

• Astera Labs shares jumped 12.4% to $340.74 on elevated trading volume, giving the company a market capitalization of approximately $59.1 billion.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $348.33; recent targets range from $325 to $450.
• The company reported strong quarterly results, including $0.80 in adjusted earnings per share and $392.4 million in revenue, up 104.5% year over year. However, insiders have sold roughly $209.7 million of stock over the past 90 days.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares rose 12.4% during trading on Monday . The stock traded as high as $343.00 and last traded at $340.74. Approximately 6,070,613 shares changed hands during trading, an increase of 15% from the average daily volume of 5,258,738 shares. The stock had previously closed at $303.25.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALAB. Jefferies Financial Group boosted their price target on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Morgan Stanley lifted their price objective on Astera Labs to $335.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Northland Securities raised Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 target price for the company in a research report on Monday, August 17th. Barclays upped their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research note on Monday, July 20th. Finally, UBS Group reiterated a "neutral" rating and issued a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $348.33.

Astera Labs Stock Performance

The stock has a market capitalization of $59.11 billion, a P/E ratio of 168.68 and a beta of 3.77. The firm has a fifty day moving average price of $303.33 and a two-hundred day moving average price of $266.42.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. Astera Labs's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total transaction of $963,734.80. Following the sale, the director directly owned 50,456 shares of the company's stock, valued at approximately $13,873,381.76. The trade was a 6.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 592,244 shares of company stock worth $209,729,973. Company insiders own 10.40% of the company's stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs during the 4th quarter valued at about $18,708,000. Swedbank AB increased its holdings in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company's stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in Astera Labs in the 4th quarter worth approximately $499,000. Revere Asset Management Inc purchased a new stake in Astera Labs in the 4th quarter worth approximately $589,000. Finally, Banque Cantonale Vaudoise raised its stake in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company's stock worth $766,000 after acquiring an additional 3,229 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company's portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.